Trial NCT04478266

View at ClinicalTrials.gov 
Org. Study IDs: EFC15935
Secondary IDs: 2020-001824-33 U1111-1233-0486

Last trial update was posted on 2023-12-08

MeSH Interventions

Goserelin Letrozole Palbociclib

MeSH Conditions

Breast Neoplasms

Other Conditions

Breast Cancer

Stopping Reasons

The study was terminated based on the review by an independent data monitoring committee of the prespecified interim analysis of the Phase 3 AMEERA-5 efficacy data. No new safety signals were observed.

Limitations And Caveats

The study was terminated based on the review by an independent data monitoring committee of the prespecified interim analysis of the Phase 3 AMEERA-5 efficacy data.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID